ICU Medical, Inc. to Present at the J.P. Morgan 39th Annual Healthcare Conference
ICU Medical (Nasdaq:ICUI) announced its participation in the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ICU Medical (Nasdaq:ICUI) announced its participation in the J.P. Morgan 39th Annual Healthcare Conference, taking place virtually from January 11-14, 2021. The company's presentation is scheduled for January 13, 2021, at 8:40 a.m. PST (11:40 a.m. EST).
The event will be webcast live, accessible via the ICU Medical website under the Investors tab. The presentation will also be available for replay.
Details
News Market Reaction – ICUI
The recorded move for ICUI in the trading session of this news was +3.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 39th Annual Healthcare Conference, held virtually January 11-14, 2021.
ICU Medical’s presentation will be on Wednesday, January 13, 2021 at 8:40 a.m. PST (11:40 a.m. EST).
The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.